Plasma Fractionation Market Research Report Information by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, and Others), by Method (Cryoprecipitation, Chromatography, Ethanol Precipitation, Ultrafiltration, and Others), by Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, and Others), by End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING DEMAND FOR PLASMA-DERIVED MEDICINAL PRODUCTS (PDMPS)

4.2.2 GROWING AWARENESS AND DIAGNOSIS OF RARE DISEASES

4.2.3 RISING GERIATRIC POPULATION ACROSS THE GLOBE

4.3 RESTRAINTS

4.3.1 EMERGENCE OF RECOMBINANT THERAPIES AS AN ALTERNATIVE TO PLASMA-DERIVED MEDICINES

4.4 OPPORTUNITY

4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL PLASMA FRACTIONATION MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON KEY PLAYERS

6 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 IMMUNOGLOBULIN

6.2.1 INTRAVENOUS IMMUNOGLOBULINS

6.2.2 SUBCUTANEOUS IMMUNOGLOBULINS

6.2.3 OTHERS

6.3 COAGULATION FACTOR CONCENTRATES

6.3.1 FACTOR VII

6.3.2 FACTOR VIII (VON WILLEBRAND FACTOR)

6.3.3 FACTOR IX

6.3.4 PROTHROMBIN COMPLEX CONCENTRATE

6.3.5 FIBRINOGEN CONCENTRATES

6.3.6 FACTOR XIII

6.4 ALBUMIN

6.5 PROTEASE INHIBITORS

6.6 OTHERS

7 GLOBAL PLASMA FRACTIONATION MARKET, BY METHOD

7.1 OVERVIEW

7.2 CRYOPRECIPITATION

7.3 CHROMATOGRAPHY

7.4 ETHANOL PRECIPITATION

7.5 ULTRAFILTRATION

7.6 OTHERS

8 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 IMMUNOLOGY

8.3 NEUROLOGY

8.4 HEMATOLOGY

8.5 CRITICAL CARE

8.6 PULMONOLOGY

8.7 RHEUMATOLOGY

8.8 ONCOLOGY

8.9 OTHERS

9 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS & CLINICS

9.3 CLINICAL RESEARCH LABORATORIES

9.4 ACADEMIC INSTITUTES

9.5 OTHERS

10 GLOBAL PLASMA FRACTIONATION MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 FRANCE

10.3.3 UK

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 BELGIUM

10.3.7 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL PLASMA FRACTIONATION MARKET

11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PLASMA FRACTIONATION MARKET

11.5 KEY DEVELOPMENT ANALYSIS

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT APPROVAL

11.6.2 ACQUISITION

11.6.3 EXPANSION

11.7 MAJOR PLAYERS FINANCIAL

11.7.1 SALES (USD MILLION), 2022

11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

12 COMPANY PROFILES

12.1 PFIZER, INC

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 FINANCIAL OVERVIEW

12.1.6 KEY STRATEGIES

12.2 BIO PRODUCTS LABORATORY LTD

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 KEY STRATEGIES

12.3 KEDRION S.P.A

12.3.1 COMPANY OVERVIEWS

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 KEY STRATEGIES

12.4 ADMA BIOLOGICS, INC

12.4.1 COMPANY OVERVIEWS

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 KEY STRATEGIES

12.5 JAPAN BLOOD PRODUCTS ORGANIZATION

12.5.1 COMPANY OVERVIEWS

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 KEY STRATEGIES

12.6 GRIFOLS, S.A.

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 SWOT ANALYSIS

12.6.6 KEY STRATEGIES

12.7 TAKEDA PHARMACEUTICAL COMPANY LIMITED

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 CSL

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 OCTAPHARMA AG

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 KEY STRATEGIES

12.10 KM BIOLOGICS

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 3 GLOBAL PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULIN, BY REGION, 2019–2032 (USD MILLION)

TABLE 4 GLOBAL PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULIN, BY TYPE, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL PLASMA FRACTIONATION MARKET, FOR INTRAVENOUS IMMUNOGLOBULINS BY REGION, 2019–2032 (USD MILLION)

TABLE 6 GLOBAL PLASMA FRACTIONATION MARKET, FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY REGION, 2019–2032 (USD MILLION)

TABLE 7 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 8 GLOBAL PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY REGION, 2019–2032 (USD MILLION)

TABLE 9 GLOBAL PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 10 GLOBAL PLASMA FRACTIONATION MARKET, FOR FACTOR VII, BY REGION, 2019–2032 (USD MILLION)

TABLE 11 GLOBAL PLASMA FRACTIONATION MARKET, FOR FACTOR VIII (VON WILLEBRAND FACTOR), BY REGION, 2019–2032 (USD MILLION)

TABLE 12 GLOBAL PLASMA FRACTIONATION MARKET, FOR FACTOR IX, BY REGION, 2019–2032 (USD MILLION)

TABLE 13 GLOBAL PLASMA FRACTIONATION MARKET, FOR PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2019–2032 (USD MILLION)

TABLE 14 GLOBAL PLASMA FRACTIONATION MARKET, FOR FIBRINOGEN CONCENTRATES, BY REGION, 2019–2032 (USD MILLION)

TABLE 15 GLOBAL PLASMA FRACTIONATION MARKET, FOR FACTOR XIII, BY REGION, 2019–2032 (USD MILLION)

TABLE 16 GLOBAL PLASMA FRACTIONATION MARKET, FOR C ALBUMIN, BY REGION, 2019–2032 (USD MILLION)

TABLE 17 GLOBAL PLASMA FRACTIONATION MARKET, FOR PROTEASE INHIBITORS, BY REGION, 2019–2032 (USD MILLION)

TABLE 18 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 19 GLOBAL PLASMA FRACTIONATION MARKET, BY METHOD, 2019–2032 (USD MILLION)

TABLE 20 GLOBAL PLASMA FRACTIONATION MARKET, FOR CRYOPRECIPITATION, BY REGION, 2019–2032 (USD MILLION)

TABLE 21 GLOBAL PLASMA FRACTIONATION MARKET, FOR CHROMATOGRAPHY, BY REGION, 2019–2032 (USD MILLION)

TABLE 22 GLOBAL PLASMA FRACTIONATION MARKET, FOR ETHANOL PRECIPITATION, BY REGION, 2019–2032 (USD MILLION)

TABLE 23 GLOBAL PLASMA FRACTIONATION MARKET, FOR ULTRAFILTRATION, BY REGION, 2019–2032 (USD MILLION)

TABLE 24 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 25 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 26 GLOBAL PLASMA FRACTIONATION MARKET, FOR IMMUNOLOGY, BY REGION, 2019–2032 (USD MILLION)

TABLE 27 GLOBAL PLASMA FRACTIONATION MARKET, FOR NEUROLOGY, BY REGION, 2019–2032 (USD MILLION)

TABLE 28 GLOBAL PLASMA FRACTIONATION MARKET, FOR HEMATOLOGY, BY REGION, 2019–2032 (USD MILLION)

TABLE 29 GLOBAL PLASMA FRACTIONATION MARKET, FOR CRITICAL CARE, BY REGION, 2019–2032 (USD MILLION)

TABLE 30 GLOBAL PLASMA FRACTIONATION MARKET, FOR PULMONOLOGY, BY REGION, 2019–2032 (USD MILLION)

TABLE 31 GLOBAL PLASMA FRACTIONATION MARKET, FOR RHEUMATOLOGY, BY REGION, 2019–2032 (USD MILLION)

TABLE 32 GLOBAL PLASMA FRACTIONATION MARKET, FOR ONCOLOGY, BY REGION, 2019–2032 (USD MILLION)

TABLE 33 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 34 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 35 GLOBAL PLASMA FRACTIONATION MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019–2032 (USD MILLION)

TABLE 36 GLOBAL PLASMA FRACTIONATION MARKET, FOR CLINICAL RESEARCH LABORATORIES, BY REGION, 2019–2032 (USD MILLION)

TABLE 37 GLOBAL PLASMA FRACTIONATION MARKET, FOR ACADEMIC INSTITUTES, BY REGION, 2019–2032 (USD MILLION)

TABLE 38 GLOBAL PLASMA FRACTIONATION MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 39 GLOBAL: PLASMA FRACTIONATION MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 40 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 41 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 42 NORTH AMERICA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 43 NORTH AMERICA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 44 NORTH AMERICA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 45 NORTH AMERICA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 46 NORTH AMERICA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 47 US: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 48 US: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 49 US: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 50 US: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 51 US: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 52 US: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 53 CANADA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 54 CANADA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 55 CANADA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 56 CANADA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 57 CANADA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 58 CANADA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 59 EUROPE: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 60 EUROPE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 61 EUROPE: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 62 EUROPE: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 63 EUROPE: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 64 EUROPE: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 65 EUROPE: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 66 GERMANY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 67 GERMANY: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 68 GERMANY: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 69 GERMANY: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 70 GERMANY: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 71 GERMANY: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 72 FRANCE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 73 FRANCE: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 74 FRANCE: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 75 FRANCE: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 76 FRANCE: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 77 FRANCE: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 78 UK: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 79 UK: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 80 UK: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 81 UK: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 82 UK: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 83 UK: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 84 ITALY: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 85 ITALY: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 86 ITALY: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 87 ITALY: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 88 ITALY: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 89 ITALY: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 90 SPAIN: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 91 SPAIN: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 92 SPAIN: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 93 SPAIN: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 94 SPAIN: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 95 SPAIN: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 96 BELGIUM: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 97 BELGIUM: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 98 BELGIUM: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 99 BELGIUM: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 100 BELGIUM: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 101 BELGIUM: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 102 REST OF EUROPE: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 103 REST OF EUROPE: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 104 REST OF EUROPE: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 105 REST OF EUROPE: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 106 REST OF EUROPE: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 107 REST OF EUROPE: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 108 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 109 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 110 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 111 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 112 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 113 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 114 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 115 CHINA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 116 CHINA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 117 CHINA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 118 CHINA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 119 CHINA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 120 CHINA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 121 INDIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 122 INDIA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 123 INDIA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 124 INDIA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 125 INDIA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 126 INDIA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 127 JAPAN: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 128 JAPAN: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 129 JAPAN: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 130 JAPAN: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 131 JAPAN: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 132 JAPAN: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 133 SOUTH KOREA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 134 SOUTH KOREA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 135 SOUTH KOREA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 136 SOUTH KOREA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 137 SOUTH KOREA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 138 SOUTH KOREA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 139 AUSTRALIA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 140 AUSTRALIA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 141 AUSTRALIA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 142 AUSTRALIA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 143 AUSTRALIA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 144 AUSTRALIA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 145 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 146 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 147 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 148 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 149 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 150 REST OF ASIA-PACIFIC: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 151 REST OT THE WORLD: PLASMA FRACTIONATION MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 152 REST OF THE WORLD: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 153 REST OF THE WORLD: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 154 REST OF THE WORLD: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 155 REST OF THE WORLD: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 156 REST OF THE WORLD: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 157 REST OF THE WORLD: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 158 MIDDLE EAST: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 159 MIDDLE EAST: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 160 MIDDLE EAST: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 161 MIDDLE EAST: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 162 MIDDLE EAST: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 163 MIDDLE EAST: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 164 AFRICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 165 AFRICA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 166 AFRICA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 167 AFRICA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 168 AFRICA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 169 AFRICA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 170 LATIN AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT, 2019–2032 (USD MILLION)

TABLE 171 LATIN AMERICA: PLASMA FRACTIONATION MARKET, FOR IMMUNOGLOBULINS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 172 LATIN AMERICA: PLASMA FRACTIONATION MARKET, FOR COAGULATION FACTOR CONCENTRATES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 173 LATIN AMERICA: PLASMA FRACTIONATION MARKET BY METHOD, 2019–2032 (USD MILLION)

TABLE 174 LATIN AMERICA: PLASMA FRACTIONATION MARKET BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 175 LATIN AMERICA: PLASMA FRACTIONATION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 176 MAJOR PLAYERS IN THE GLOBAL PLASMA FRACTIONATION MARKET

TABLE 177 BENCHMARKING OF MAJOR COMPETITORS

TABLE 178 MOST ACTIVE PLAYER IN THE GLOBAL PLASMA FRACTIONATION MARKET

TABLE 179 PRODUCT APPROVAL

TABLE 180 ACQUISITION

TABLE 181 EXPANSION

TABLE 182 PFIZER, INC: PRODUCTS OFFERED

TABLE 183 PFIZER, INC.: KEY DEVELOPMENTS

TABLE 184 BIO PRODUCTS LABORATORY LTD: PRODUCTS OFFERED

TABLE 185 KEDRION S.P.A: PRODUCTS OFFERED

TABLE 186 KEDRION S.P.A: KEY DEVELOPMENTS

TABLE 187 ADMA BIOLOGICS, INC: PRODUCTS OFFERED

TABLE 188 ADMA BIOLOGICS, INC: KEY DEVELOPMENTS

TABLE 189 JAPAN BLOOD PRODUCTS ORGANIZATION: PRODUCTS OFFERED

TABLE 190 GRIFOLS, S.A.: PRODUCTS OFFERED

TABLE 191 GRIFOLS, S.A.: KEY DEVELOPMENTS

TABLE 192 TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCTS OFFERED

TABLE 193 TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY DEVELOPMENTS

TABLE 194 CSL: PRODUCTS OFFERED

TABLE 195 CSL: KEY DEVELOPMENTS

TABLE 196 OCTAPHARMA AG: PRODUCTS OFFERED

TABLE 197 OCTAPHARMA AG: KEY DEVELOPMENTS

TABLE 198 KM BIOLOGICS: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 2 MARKET DYNAMICS: GLOBAL PLASMA FRACTIONATION MARKET

FIGURE 3 DRIVER IMPACT ANALYSIS

FIGURE 4 RESTRAINT IMPACT ANALYSIS

FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL PLASMA FRACTIONATION MARKET

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PLASMA FRACTIONATION MARKET

FIGURE 7 GLOBAL PLASMA FRACTIONATION MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)

FIGURE 8 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION)

FIGURE 9 GLOBAL PLASMA FRACTIONATION MARKET SHARE (%), BY PRODUCT, 2022

FIGURE 10 GLOBAL PLASMA FRACTIONATION MARKET, METHOD SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)

FIGURE 11 GLOBAL PLASMA FRACTIONATION MARKET, BY METHOD, 2022 & 2032 (USD MILLION)

FIGURE 12 GLOBAL PLASMA FRACTIONATION MARKET SHARE (%), BY METHOD, 2022

FIGURE 13 GLOBAL PLASMA FRACTIONATION MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)

FIGURE 14 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION, 2022 & 2032 (USD MILLION)

FIGURE 15 GLOBAL PLASMA FRACTIONATION MARKET SHARE (%), BY APPLICATION, 2022

FIGURE 16 GLOBAL PLASMA FRACTIONATION MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)

FIGURE 17 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER, 2022 & 2032 (USD MILLION)

FIGURE 18 GLOBAL PLASMA FRACTIONATION MARKET SHARE (%), BY END USER, 2022

FIGURE 19 GLOBAL: PLASMA FRACTIONATION MARKET, BY REGION, 2022 & 2030 (USD MILLION)

FIGURE 20 GLOBAL: PLASMA FRACTIONATION MARKET SHARE (%), BY REGION, 2022

FIGURE 21 NORTH AMERICA MARKET ANALYSIS: PLASMA FRACTIONATION MARKET, 2019-2032 (USD MILLION)

FIGURE 22 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)

FIGURE 23 NORTH AMERICA: PLASMA FRACTIONATION MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 24 EUROPE MARKET ANALYSIS: PLASMA FRACTIONATION MARKET, 2019-2032 (USD MILLION)

FIGURE 25 EUROPE: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)

FIGURE 26 EUROPE: PLASMA FRACTIONATION MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 27 ASIA-PACIFIC MARKET ANALYSIS: PLASMA FRACTIONATION MARKET, 2019-2030 (USD MILLION)

FIGURE 28 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)

FIGURE 29 ASIA-PACIFIC: PLASMA FRACTIONATION MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 30 REST OF THE WORLD MARKET ANALYSIS: PLASMA FRACTIONATION MARKET, 2019-2030 (USD MILLION)

FIGURE 31 REST OT THE WORLD: PLASMA FRACTIONATION MARKET, BY REGION, 2022 & 2030 (USD MILLION)

FIGURE 32 REST OT THE WORLD: PLASMA FRACTIONATION MARKET SHARE (%), BY REGION, 2022

FIGURE 33 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PLASMA FRACTIONATION MARKET

FIGURE 34 GLOBAL PLASMA FRACTIONATION MARKET: COMPETITIVE LANDSCAPE

FIGURE 35 MAJOR PLAYERS SALES (USD MILLION), 2022

FIGURE 36 MAJOR PLAYER R&D EXPENDITURE (USD MILLION), 2022

FIGURE 37 PFIZER, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 PFIZER, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 39 KEDRION S.P.A: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 40 ADMA BIOLOGICS, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 GRIFOLS, S.A.:FINANCIAL OVERVIEW SNAPSHOT

FIGURE 42 GRIFOLS, S.A.: SWOT ANALYSIS

FIGURE 43 TAKEDA PHARMACEUTICAL COMPANY LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 44 TAKEDA PHARMACEUTICAL COMPANY LIMITED: SWOT ANALYSIS

FIGURE 45 CSL: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 46 CSL: SWOT ANALYSIS

FIGURE 47 OCTAPHARMA AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 48 OCTAPHARMA AG: SWOT ANALYSIS